Written Evidence from Spotlight on Corruption1 (PGG18) the Public
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Adherence to the Test, Trace and Isolate System
Adherence to the test, trace and isolate system: results from a time series of 21 nationally representative surveys in the UK (the COVID-19 Rapid Survey of Adherence to Interventions and Responses [CORSAIR] study) Louise E Smith (0000-0002-1277-2564),1,2 PhD, Henry WW Potts,3 PhD, Richard Amlȏt,2,4 PhD, Nicola T Fear,1,5 DPhil (Oxon), Susan Michie,6 DPhil, G James Rubin,1,2 PhD 1 King’s College London, Institute of Psychiatry, Psychology and Neuroscience 2 NIHR Health Protection Research Unit in Emergency Preparedness and Response 3 University College London, Institute of Health Informatics 4 Public Health England, Behavioural Science Team, Emergency Response Department Science and Technology 5 King’s Centre for Military Health Research 6 University College London, Centre for Behaviour Change Corresponding author: Louise E Smith, Post-doctoral Researcher. Department of Psychological Medicine, King’s College London, Weston Education Centre, Cutcombe Road, London, SE5 9RJ. Email: [email protected] Henry WW Potts, Associate Professor at the UCL Institute of Health Informatics. 222 Euston Road, London, NW1 2DA. Richard Amlȏt, Head of Behavioural Science in the Emergency Response Department at Public Health England. Porton Down, Salisbury, Wiltshire, SP4 0JG. 1 Nicola T Fear, Professor of Epidemiology. Department of Psychological Medicine, King’s College London, Weston Education Centre, Cutcombe Road, London, SE5 9RJ. Susan Michie, Professor of Health Psychology. 1-19 Torrington Place, London, WC1E 7HB. G James Rubin, Reader in the Psychology of Emerging Health Risks. Department of Psychological Medicine, King’s College London, Weston Education Centre, Cutcombe Road, London, SE5 9RJ. -
23 April 2020 Update
20 April – 23 April 2020 Contents I. Summary .............................................................................................................................1 II. European Union .................................................................................................................5 III. France ...............................................................................................................................6 IV. Italy ...................................................................................................................................7 V. Germany ............................................................................................................................8 VI. Spain ...............................................................................................................................10 VII. United Kingdom .............................................................................................................10 I. SUMMARY Number of cases: 1,009,762 (including the UK) Number of deaths: 108,223 • The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a meeting on 15 April to discuss the progress of the measures regarding availability of medicines for European patients during the COVID-19 pandemic. They also updated the Q&A document on regulatory expectations for medicinal products for human use during the COVID-19 pandemic on 20 April. On 21 April, they set-up the fast-track system to support essential medicines for COVID-19 treatment, -
KCC COVID-19 Support Guide
Kent County Council COVID-19 Update This guide includes a summary of the latest Government announcements, alongside information on KCC’s website (kent.gov.uk). The guide is updated regularly and, is not intended to be an exhaustive list of all the resources, funding and advice being issued, therefore it links to other sources of information where available. • On Tuesday, 14 September the Prime Minister announced the Government’s Autumn and Winter COVID Plan. • The Plan is split into a Plan A and Plan B. • Plan A is “an approach designed to steer the country through autumn and winter 2021-22”, “while ensuring the NHS does not come under unsustainable pressure”. This includes: o Maximising uptake of a COVID-19 vaccine among those that are eligible but have not yet taken up the offer o Offering booster doses to individuals who received vaccination in Phase 1 of the COVID-19 vaccination programme (priority groups 1-9) o Offering a first dose of vaccine to 12–15-year-olds. o The Government also recommends as many people as possible receive a vaccination against flu this autumn and winter. o The Test, Trace, and Isolate system will continue over the autumn and winter. o A revised framework for international travel. o Repealing and renewing certain legislation • Plan B exists because COVID-19 “remains a risk”, and Government needs to “keep further measures in reserve”. This update comprises: • Autumn & Winter Covid Plan • Business • Vaccines • Employment • Testing • Economic Development • Levelling-up • Antibody treatments • Economy • Infection Rate AUTUMN & WINTER COVID PLAN • On Tuesday, 14 September the Prime Minister announced the Government’s Autumn and Winter COVID Plan. -
Covid-19: Test and Trace Self - Isolation Guide
Covid-19: Test and Trace Self - Isolation Guide Introduction The Test and Trace system introduced by the UK government is intended to become a central part of the strategy in the fight to get the coronavirus pandemic under control, particularly as the vaccine programme progresses and Covid measures are relaxed. This guide is designed to provide an overview of NHS Test and Trace system, including what happens if you test positive for coronavirus (Covid-19) or have had close contact with someone who has tested positive. Systems differ in each devolved nation and Republic of Ireland, see below links for: Wales Test, trace, protect coronavirus Scotland Coronavirus Covid-19 Test and Protect Northern Ireland Coronavirus Covid-19 Contact tracing ROI Covid-19 Contact Tracing Centres: Your questions answered Quick link Access to info 1. How NHS Test and Trace helps fight the virus 2. How NHS Test and Trace works 3. Exemptions from self-isolation for contacts 4. The NHS Covid-19 app 5. Part 1: people who develop symptoms of Covid-19 6. Part 2: people who have had close contact with someone who has Covid-19 7. Support for people who are self-isolating 8. NHS QR check-in codes for your venue How the Test and Trace System works when a person has Symptoms of Covid-19 Self-isolate: as soon as you experience Covid-19 symptoms, medical advice is clear: you should self-isolate for at least 10 days, unless you get a negative PCR test. Your self- isolation period includes the day your symptoms started and the next 10 full days. -
UK COVID-19 Vaccines Delivery Plan
UK COVID-19 vaccines delivery plan Published 11 January 2021 Contents 1. Ministerial foreword ....................................................................................................... 3 2. Executive summary and scope ..................................................................................... 4 Supply .............................................................................................................................. 5 Prioritisation ...................................................................................................................... 6 Places ............................................................................................................................... 7 People .............................................................................................................................. 8 Tracking our progress ....................................................................................................... 9 3. Supply ......................................................................................................................... 10 Developing new vaccines ............................................................................................... 10 Ensuring vaccines meet strict safety standards for deployment ..................................... 17 Building UK manufacturing capability ............................................................................. 21 4. Prioritisation ............................................................................................................... -
NHS Test and Trace: the Journey So Far
Health Foundation long read (PDF version) 23 September 2020 NHS Test and Trace: the journey so far Adam Briggs, Deborah Jenkins, Caroline Fraser Contents Key points 3 Introduction 4 What is NHSTT? 5 Challenges facing NHSTT 17 What next for NHSTT? 23 Conclusion 25 NHS Test and Trace: the journey so far 2 Key points • Testing for COVID-19 to identify cases and close contacts of those who test positive, alongside asking those close contacts to isolate, is essential to control the spread of the disease. • NHS Test and Trace launched on 28 May 2020 and although progress has been made, it is not yet the ‘world-beating’ contact tracing programme that was promised, with ongoing challenges around test capacity and contacting both cases and their contacts. • Despite significant investment, only between 50% and 60% of contacts of known cases are being advised to isolate, yet the government’s Scientific Advisory Group for Emergencies (SAGE) has suggested that for a contact tracing system to be effective, it needs to trace around 80% of contacts of an index case. • As cases in England rise, the government needs to urgently learn from the journey so far to ensure that tests are available for those who need them and that policies aimed at improving contact tracing do not further exacerbate the inequalities already exposed by COVID-19. NHS Test and Trace: the journey so far 3 Introduction As of 22 September, over 340,000 people in England have tested positive for SARS-CoV-2, with more than 37,000 confirmed deaths. While there is currently no approved vaccine, testing for COVID-19 to identify possible close contacts of those who test positive, and asking those close contacts to isolate, remains crucial for the control of the disease. -
COVID-19 Interim Vaccination Plan V.5 Pennsylvania
COVID-19 Interim Vaccination Plan V.5 Pennsylvania PA COVID-19 Vaccine Task Force/PA Department of Health JANUARY 19, 2021 |VERSION 5.0 PENNSYLVANIA COVID-19 INTERIM VACCINATION PLAN Table of Contents Introduction……………………………………………………………………………………………………………………………………….2 Section 1: COVID-19 Vaccination Preparedness Planning ......................................................................... 3 Section 2: COVID-19 Organizational Structure and Partner Involvement ................................................. 4 Section 3: Phased Approach to COVID-19 Vaccination ........................................................................... 11 Section 4: Critical Populations ................................................................................................................. 17 Section 5: COVID-19 Provider Recruitment and Enrollment ................................................................... 21 Section 6: COVID-19 Vaccine Administration Capacity ........................................................................... 25 1. Health and Medical Infrastructure .......................................................................................... 25 2. Occupational Health Clinics and Closed Points of Dispensing (PODs) ..................................... 26 3. Expanded Outreach to Ensure Vaccine Access ........................................................................ 27 4. Staffing .................................................................................................................................... -
Election Results – Know Your Councillors Website Upgrade – Do More Online Summer of Cycling Dear Resident
Summer 2021 www.gateshead.gov.uk Election results – Know your councillors Website upgrade – do more online Summer of cycling Dear resident Since the last edition of Maintaining the ability to provide these essential Council News in December services remains our top priority, which unfortunately 2020, COVID-19 has means we were unable to fully reopen all of our leisure continued to impact us all. and library facilities in line with the government’s We have endured another roadmap out of lockdown. I understand that many national lockdown and of you will have been disappointed by this decision sadly, lost many more lives. but adopting a phased approach to reopening has enabled us to continue protecting the health and However, we are now in wellbeing of our communities. a much stronger position than we were then. The vaccination programme is Thank you for your patience and understanding. continuing to progress at pace and the infection rate Thank you also to those who took part in our health remains much lower than it was, thanks to the efforts and wellbeing survey a few months ago – your views of residents, our wonderful NHS and other partners. will be used to shape how we deliver these services longer term. We will share more information on this I remain extremely grateful to all Gateshead Council soon. employees who have continued to serve our communities throughout the pandemic. Many of Finally, although we have every reason to feel them have taken on different roles and new ways optimistic, I must remind you that the pandemic is of working, from supporting NHS Test and Trace to not yet over and as ever, we can’t afford to become providing practical assistance through our community complacent. -
Role and Responsibilities of the Chair of the Vaccine Taskforce
Chair of the Vaccine Taskforce Information pack for applicants Closing date: Midday on Friday 14 May 2021 Reference no: VAC-1775 Follow us on Twitter @appointmentsdh Table of Contents Section 1: Role, responsibilities and person specification.................................................... 2 Section 2: How to apply ....................................................................................................... 4 2.1 Making an application ............................................................................................. 4 2.2 The selection process ............................................................................................. 7 2.3 Eligibility criteria ...................................................................................................... 9 2.4 How we will manage your personal information .................................................... 10 Chair of the Vaccine Taskforce - Information pack for applicants Section 1: Role and responsibilities of the Chair of the Vaccine Taskforce The Chair must enable the Vaccine Taskforce to achieve their three core objectives during the pandemic period: a. To secure access to promising vaccine/s for the UK population. b. To make provision for international distribution of vaccines. c. To strengthen the UK’s onshore capacity and capability in vaccine development, manufacturing, and supply chain to provide resilience for this and future pandemics. In recognising that the Taskforce has now been in existence for over a year, delivering these objectives -
WHO Backs Rollout of Astrazeneca Vaccine
this week TWINS page 423 • VACCINATING CHILDREN page 424 • BRITISH CYCLING page 427 FRANK HOERMANN/DPA/PA/ALAMY FRANK WHO backs rollout of AstraZeneca vaccine Doctors have warned of the risks associated On 16 March WHO’s chief scientist, Soumya The World Health Organization with pausing or delaying vaccination Swaminathan, said, “We do not want has urged people not to panic programmes against covid-19, as the people to panic, and we would, for the time amid reports of blood clotting number of European countries that have being, recommend that countries continue disorders in patients receiving the vaccine halted use of the Oxford University and vaccinating with AstraZeneca . So far, we AstraZeneca vaccine rose to 16. do not fi nd an association between these Denmark, Norway, Bulgaria, Iceland, events and the vaccine.” France, Germany, Italy, Spain, Portugal, The EMA said there had been 30 reports Slovenia, and Cyprus have suspended all of thromboembolic events among nearly use of the vaccine. Five other countries fi ve million people given the AstraZeneca (Austria, Estonia, Latvia, Lithuania, and vaccine in the European Economic Area. Luxembourg) have paused the use of a AstraZeneca has said 37 blood clots have LATEST ONLINE batch of a million doses of the vaccine. been reported among more than 17 million NHS and social The moves came after reports of people vaccinated in the EU and Britain. care need an extra blood clotting disorders. The Norwegian Five of the cases were deep vein thrombosis, £12bn to get back Medicines Agency said last week it was and 22 were pulmonary embolisms. -
UKC Monthly Summary 2020 July.Odt
UK COLUMN CONTENT – July 2020 https://www.ukcolumn.org/ukcolumn-news-archive 01st July 2020 Brian Gerrish and Mike Robinson with today's UK Column News. START – Good news: excess mortality rate falls below five-year average Leicester local lockdown – police to spot-check cars leaving the restricted zone… Government provides details without showing any evidence to support them SAGE recommended ramping up fear and turning communities against each other The Ferguson effect: a similar situation occurred with Foot & Mouth – community division This policy seems deliberate by the UK ‘government of occupation’ Increased Covid-19 testing will obviously result in an increase in reported cases Is this a trial run and normalisation of ‘City State’ powers…? CoronaVirus found in waste water as early as March 2019 in Spain The spike in excess deaths across the world happened after lockdown… 15:49 – More fear: schools, hospitals and offices told to prepare for ‘marauding’ terror attacks Mail Online: is your teen secretly struggling with depression…? Mail Online: workers’ health starts to fail at the age of 59 MSM complains about Covid-19 infodemic – the ‘wrong’ kind of information… 19:28 – David Noakes (GcMAF) contact information CoronaVirus: Upper Crust owner blames lockdown for 5,000 UK redundancies Michael Gove quotes Franklin Delano Roosevelt in Brexit comments Gove suggests that change is coming to the UK Civil Service Boris announces a ‘new deal’ - ‘the opportunity is massive’ The MainStream Media reaction to Boris…? Nothing, silence… MSM too busy -
MCC VA COVID-19 Vaccine Provider FAQ May 2021
COVID-19 Vaccine Provider FAQs We are actively monitoring COVID-19 vaccine developments. Below you will find helpful information and answers to some of the most frequently asked questions about COVID-19 vaccines. Magellan Complete Care has a COVID-19 Vaccine Taskforce comprised of experts, including clinicians, health plan leadership, and pharmacy network team members that meets regularly to discuss the latest developments and plan support. We are monitoring government guidance at the federal and state levels. We are taking steps to ensure you have the information you need as the information and guidelines are made available by federal and state agencies. Vaccine Development and Distribution Operation Warp Speed (OWS) was set up by the White House to coordinate efforts among federal government entities, states, and private sector partners. It aims to accelerate the testing, supply, development, and distribution of safe and effective vaccines, therapeutics, and diagnostics. There are many government agencies involved in helping with the COVID-19 pandemic. A few of the key agencies are listed below for your reference: • Food and Drug Administration (FDA) – The FDA reviews and approves or authorizes safe and effective vaccines. • Centers for Disease Control and Prevention (CDC) – The CDC is responsible for controlling the introduction and spread of infectious diseases. • Advisory Committee on Immunization Practices (ACIP) – ACIP is a committee within the CDC that provides advice and guidance on effective control of vaccine-preventable diseases in the U.S. civilian population. • National Academies of Science Engineering & Medicine (NASEM) – The National Institutes of Health (NIH) and CDC have tasked NASEM to develop a plan for equitable allocation of vaccines.